Cargando…

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases

BACKGROUND: Because atopic dermatitis does not heal completely, associated severe atopic keratoconjunctivitis (AKC) and vernal keratoconjunctivitis (VKC) often require long-term treatment. This study aims to evaluate the long-term outcomes of using 0.1% tacrolimus eye drops to treat these severe all...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yazu, Hiroyuki, Fukagawa, Kazumi, Shimizu, Eisuke, Sato, Yasunori, Fujishima, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852099/ https://www.ncbi.nlm.nih.gov/pubmed/33522964 http://dx.doi.org/10.1186/s13223-021-00513-w

Ejemplares similares

Clinical Observation of Allergic Conjunctival Diseases with Portable and Recordable Slit-Lamp Device
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement
por: Fukushima, Atsuki, et al.
Publicado: (2014)

Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension
por: Fujishima, Hiroshi, et al.
Publicado: (2020)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

"Smart Eye Camera": An innovative technique to evaluate tear film breakup time in a murine dry eye disease model
por: Shimizu, Eisuke, et al.
Publicado: (2019)

58 Long-term IFN-γ Treatment Alters Allergic Inflammation-Associated Gene Expression in Conjunctival Fibroblasts
por: Okada, Naoko, et al.
Publicado: (2012)

Combination Therapy of 0.1% Fluorometholone and 0.05% Azelastine in Eyes with Severe Allergic Conjunctival Diseases: A Randomized Controlled Trial
por: Chen, Minjie, et al.
Publicado: (2022)

Comparison of 0.1%, 0.18%, and 0.3% Hyaluronic Acid Eye Drops in the Treatment of Experimental Dry Eye
por: You, In Cheon, et al.
Publicado: (2018)

Smart Eye Camera: A Validation Study for Evaluating the Tear Film Breakup Time in Human Subjects
por: Shimizu, Eisuke, et al.
Publicado: (2021)

Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2019)

Allergic Contact Dermatitis to Eye Drops
por: Bhat, Yasmeen Jabeen, et al.
Publicado: (2015)

Elevated levels of prostaglandin E(2) in the tears of patients with severe allergic conjunctivitis and primary cultured conjunctival cells are suppressed by ketotifen and dexamethasone
por: Yamanishi, Ryutaro, et al.
Publicado: (2021)

Combination of Two Rapid Ophthalmic Test Kits for Improved Diagnosis in Cases of Severe Binocular Conjunctivitis
por: Kodama, Asako, et al.
Publicado: (2020)

Comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Jethani, Jitendra, et al.
Publicado: (2020)

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
por: Hazarika, Ajit Kumar, et al.
Publicado: (2015)

Development and Characterization of a Tacrolimus/Hydroxypropyl-β-Cyclodextrin Eye Drop
por: García-Otero, Xurxo, et al.
Publicado: (2021)

Evaluation of Nuclear Cataract with Smartphone-Attachable Slit-Lamp Device
por: Yazu, Hiroyuki, et al.
Publicado: (2020)

Response to comments on: Changes in pattern electroretinogram after application of 0.01% atropine eye drops
por: Kothari, Mihir, et al.
Publicado: (2020)

Topical steroids eye drops in conjunctival reactive lymphoid hyperplasia: Case report
por: Moraes, Bernardo Rodrigues Mendes, et al.
Publicado: (2017)

Randomized, Multicenter, Double–Blind Study of the Safety and Efficacy of 1%D-3-Hydroxybutyrate eye drops for Dry Eye Disease
por: Kawakita, Tetsuya, et al.
Publicado: (2016)

Effects of Long-Term Antiglaucoma Eye Drops on Conjunctival Structures: An In Vivo Confocal Microscopy Study
por: Zhu, Wenqing, et al.
Publicado: (2015)

Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
por: Uchio, Eiichi
Publicado: (2008)

Effect of low-concentration atropine (0.01%) eye drops on higher-order aberrations in myopic children
por: Jethani, Jitendra, et al.
Publicado: (2021)

Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Biopolymers in Mucoadhesive Eye Drops for Treatment of Dry Eye and Allergic Conditions: Application and Perspectives
por: Račić, Anđelka, et al.
Publicado: (2023)

Incremental Concentrations of Tacrolimus Eye Drops as a Strategy for the Management of Severe Vernal Keratoconjunctivitis
por: Albarry, Maan Abdullah, et al.
Publicado: (2022)

Comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Patil, Ankita A, et al.
Publicado: (2022)

Evaluation of conjunctival inflammatory status by confocal scanning laser microscopy and conjunctival brush cytology in patients with atopic keratoconjunctivitis (AKC)
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2009)

Effect of Liposomal-Lactoferrin-Based Eye Drops on the Conjunctival Microflora of Patients Undergoing Cataract Surgery
por: Giannaccare, Giuseppe, et al.
Publicado: (2023)

Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops Vs Olopatadine Hydrochloride 0.2% Bak-Preserved Eye Drops in Patients with Allergic Conjunctivitis
por: Marini, María Cecilia, et al.
Publicado: (2023)

Impact of benzalkonium chloride-preserved and preservative-free latanoprost eye drops on cultured human conjunctival goblet cells upon acute exposure and differences in physicochemical properties of the eye drops
por: Müllertz, Olivia, et al.
Publicado: (2021)

Convergence excess consecutive esotropia associated with 0.01% atropine eye drops usage in patients operated for intermittent exotropia
por: Kothari, Mihir, et al.
Publicado: (2020)

Response to comment on: Efficacy of low-concentration atropine (0.01%) eye drops for prevention of axial myopic progression in premyopes
por: Jethani, Jitendra
Publicado: (2022)

Allergic Contact Dermatitis Caused by Topical Eye Drops Containing Latanoprost
por: Lee, Ji Hye, et al.
Publicado: (2014)

Allergic reactions to atropine eye drops for retardation of progressive myopia in children
por: Kothari, Mihir, et al.
Publicado: (2018)

Eosinophil cationic protein as a marker for assessing the efficacy of tacrolimus ophthalmic solution in the treatment of atopic keratoconjunctivitis
por: Wakamatsu, Tais Hitomi, et al.
Publicado: (2011)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Successful treatment of allergic conjunctival granuloma by topical tacrolimus: A clinicopathologic case report
por: Foroutan, Alireza, et al.
Publicado: (2018)

Generic benzalkonium chloride‐preserved travoprost eye drops are not identical to the branded polyquarternium‐1‐preserved travoprost eye drop: Effect on cultured human conjunctival goblet cells and their physicochemical properties
por: Hedengran, Anne, et al.
Publicado: (2022)

Atropine 0.01% Eye Drops for Myopia Control in American Children: A Multiethnic Sample Across Three US Sites
por: Larkin, G. Luke, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_knmtagsfemausp2e5maqg1rnr1